How long does oral semaglutide take to work? Each tablet reaches its peak blood level about 1 hour after you take it, but steady levels take 4 to 5 weeks of daily use, according to its label. Weight loss builds over months: in the OASIS 4 trial, average loss was 13.6% at 64 weeks, compared with 2.2% on placebo.
Written by Kiara DeWitt, BSN, RN
Medically reviewed by Dr. Josh Allen, D.O., Medical Director on October 29, 2026
Medical disclaimer: Medical weight loss treatment is prescribed only after a clinical consultation and is not appropriate for everyone. Whether you are a candidate is decided by a licensed provider, not by any tool or information on this page. Results vary between individuals and depend on adherence, diet, and activity. Compounded medications are not FDA-approved; trial results come from the brand tablet.
Semaglutide is a GLP-1 receptor agonist. It acts like a hormone your gut releases after eating, which signals fullness, slows digestion, and helps regulate blood sugar.
As a tablet, semaglutide has to get through the stomach, which is harder than it sounds. According to the semaglutide tablet prescribing information, only about 1% to 2% of each tablet’s semaglutide reaches the bloodstream. By comparison, the label puts absorption from a weekly injection at 89%.
That low absorption explains the tablet’s strict routine. Food, other drinks, or extra water in the stomach can reduce how much gets absorbed, so the label sets out exactly how to take it. That routine is covered further down.
According to its label, a semaglutide tablet reaches its maximum concentration in the blood about 1 hour after you take it. You won’t feel this. It’s the start of a build-up, not the full effect.
Semaglutide stays in the body a long time. Its half-life, the time it takes for blood levels to fall by half, is about 1 week. Because of that, levels build with each daily dose. The diabetes tablet prescribing information says steady blood levels are reached after 4 to 5 weeks of once-daily use.
That’s one reason the first few weeks can feel quiet, and why your provider looks at your progress over months rather than days.
Appetite changes are often the first thing people notice. In a 2021 study by Gibbons and colleagues, 15 adults with type 2 diabetes took oral semaglutide for 12 weeks and a placebo for 12 weeks, in random order. On test days where they could eat freely, the 13 people with complete data ate 38.9% less over the day on semaglutide than on placebo.
That was a small study in people with diabetes, so it shows the direction of the effect, not what any one person will feel or when.
Weight loss on oral semaglutide happens gradually. The two main trials show what that looked like on average:
These are averages across many people over more than a year, not promises. Some people lost more and some lost less.
People often use “oral semaglutide” for two very different products. Keeping them apart matters:
| Brand tablets | Compounded sublingual drops | |
|---|---|---|
| How it’s taken | Swallowed once a day | Placed under the tongue |
| FDA status | FDA-approved with prescribing information | Not FDA-approved |
| Large human weight-loss trials | Yes (OASIS program) | None |
| Absorption data | Published in the label | Not established in large human studies |
| Where trial results apply | To the tablets studied | Not to drops |
The brand tablets are Wegovy tablets and Rybelsus, according to their FDA prescribing information. Compounded drops are prepared by a compounding pharmacy for an individual prescription. According to the FDA, compounded drugs are not FDA approved, and the agency does not review them for safety, effectiveness, or quality before they are marketed.
Compounded drops are not the same as a tablet, and the trial numbers on this page come from the tablets only. You can read more about compounded sublingual semaglutide drops.
The brand tablet and the weekly injection both contain semaglutide, but they absorb very differently. According to the label, about 1% to 2% of a tablet’s semaglutide is absorbed, compared with 89% from the injection, which is why the tablet is taken every day.
The label adds that in people without type 2 diabetes, average blood levels on the daily weight-management tablet and the weekly injection were similar. In people with type 2 diabetes, levels on the tablet were lower and more variable. Your provider can explain which form fits your health history. For a full comparison, read oral vs injectable semaglutide.
Taking it as labeled. The label says to take the tablet once a day on an empty stomach in the morning, with up to 4 ounces of water. After taking it, wait at least 30 minutes before eating, drinking, or taking other oral medications.
Consistency. Blood levels build with daily use, so missed or late doses slow that build-up.
Side effects. Stomach side effects are common. In OASIS 1, gastrointestinal side effects were reported in 80% of people on the tablet, compared with 46% on placebo, and were mostly mild to moderate. In OASIS 4, the rates were 74% and 42%. Your provider can help you manage these so you can stay on track.
Lifestyle support. Participants in both OASIS trials also followed a lifestyle program, so the averages reflect medication plus diet and activity changes.
Each of these goes against the label’s instructions:
Yes. InjectCo’s needle-free option is compounded sublingual semaglutide drops, part of our medical weight loss program at $425 a month with home delivery across Texas. The drops are compounded medication and are not the brand tablet.
Because there are no large human weight-loss trials for compounded drops, your nurse tracks your progress and adjusts your plan based on how you respond.
Ask our nurses whether compounded sublingual drops fit your plan, delivered to your door in Texas.
$425 a month, or $1,800 for a 6 to 8 month program
About 1 hour to peak and 4 to 5 weeks to steady levels, according to the tablet’s label. Weight loss builds over months: in OASIS 4, average loss was 13.6% at 64 weeks, compared with 2.2% on placebo. These are averages, not promises.
Appetite often changes first, but timing varies. In a 2021 study of adults with type 2 diabetes, people ate 38.9% less on a test day after 12 weeks on oral semaglutide than after 12 weeks on placebo.
In clinical trials, average weight loss was 13.6% at 64 weeks in OASIS 4, compared with 2.2% on placebo, and 15.1% at 68 weeks with a higher-strength tablet in OASIS 1. These are averages, not promises. For more, see how much weight people lose on semaglutide.
The trials on this page compared each form with placebo, not with each other. The label notes that in people without type 2 diabetes, average blood levels on the daily weight-management tablet were similar to the weekly injection. In people with type 2 diabetes, tablet levels were lower. Your provider can help you decide which form fits.
There’s no large trial to say. There are no large human weight-loss trials for compounded sublingual semaglutide drops, and they are not FDA-approved. The tablet trial results don’t apply to drops. Your nurse tracks your progress if drops are part of your plan.
There’s no trial data on timing for compounded drops. Your nurse monitors your appetite, weight, and side effects over time and adjusts your plan as needed.
Skip it. According to the label, skip the missed dose and take your next tablet the following day as usual. Don’t take two tablets to make up for it.
A nurse reviews your history before anything is prescribed.
$425 a month with home delivery
Dr. Josh Allen, D.O., is InjectCo’s Medical Director. He oversees the clinical standards behind every treatment InjectCo offers and supports its nurse injectors across all nine Texas locations. He earned his Doctor of Osteopathic Medicine at Lake Erie College of Osteopathic Medicine and completed his residency in emergency medicine with Texas A&M.
